Sign in

Lorenza Rimassa

@lorenzarimassa.bsky.social
120 followers 147 following 67 posts

Associate Professor of Medical Oncology at HUNIMED, Head of Hepatopancreatobiliary Unit at HUMANITAS, GI cancer specialist with research interest in #livercancer, #HCC, #biliarytractcancer, #cholangiocarcinoma

PostsRepliesMedia
Reposted by Lorenza Rimassa
ESMO - European Society for Medical Oncology @myesmo.bsky.social · 22/09/2026
📣 #ESMO26: The late-breaking abstract lineup is taking shape! Authors & titles are online, and most of the submissions are already there. 30K+ delegates already registered from around the world, so this means new data, new insights and new opportunities to connect. 🔗 ow.ly/6Res50ZQ82a
053
Reposted by Lorenza Rimassa
ESMO - European Society for Medical Oncology @myesmo.bsky.social · 18/09/2026
ESMO is pleased to announce the #ESMOAmbassadors for #ESMO26. They will share scientific highlights, expert perspectives and insights on the latest research presented at #ESMO26 across tumour types and disciplines. 🔗Discover the Ambassadors: ow.ly/BQ3i50ZOkEv
052
Reposted by Lorenza Rimassa
PinkNews @pinknews.bsky.social · 17/05/2026
17th May marks International Day Against Homophobia, Transphobia and Biphobia. Today is a reminder that LGBTQ+ individuals must be treated with the same empathy, respect and dignity as anyone else.
17434
Reposted by Lorenza Rimassa
European Parliament @europarl.europa.eu · 17/05/2026
The EU accepts people as they are. Hate has no place here. Parliament has backed LGBTIQ+ rights for years. Now in focus: ending conversion practices. On the International Day Against Homophobia, Biphobia and Transphobia, Parliament stands with the LGBTIQ+ community 🏳️‍🌈🏳️‍⚧️
Building of the European Parliament illuminated with a rainbow colour flag on the occasion of the International Day Against Homophobia, Biphobia and Transphobia (IDAHOBIT).
422669
Lorenza Rimassa @lorenzarimassa.bsky.social · 20/02/2026
Glad and honored to participate in the 5th Cholangiocarcinoma International Expert Meeting and in the 4th #APIC National (Italian) Meeting in Verona. #CCA #BTC
020
Reposted by Lorenza Rimassa
The New York Times @nytimes.com · 19/02/2026
From @theathletic.com: What a comeback from Amber Glenn. The American figure skater had a nearly flawless routine in her free skate after her disappointing women’s short program. “What a brilliant, redemptive skate. She just fought so hard.” nyti.ms/4arq55z
Amber Glenn gestures while skating.
914212
Reposted by Lorenza Rimassa
Bruce Springsteen @brucespringsteen.net · 28/01/2026
I wrote this song on Saturday, recorded it yesterday and released it to you today in response to the state terror being visited on the city of Minneapolis. It’s dedicated to the people of Minneapolis, our innocent immigrant neighbors and in memory of Alex Pretti and Renee Good. Stay free
youtu.be
Bruce Springsteen - Streets Of Minneapolis (Official Audio)
YouTube video by Bruce Springsteen
42569709940554
Lorenza Rimassa @lorenzarimassa.bsky.social · 24/01/2026
@acammarota.bsky.social presenting her work on clinical predictors and molecular architecture of #TLS in #CCA 🔬at @easlnews.bsky.social #LiverCancerSummit in Edinburgh. Great job! 👏🏻👏🏻👏🏻 #AnaLleo #HumanitasUniversity #Humanitas
021
Reposted by Lorenza Rimassa
American Society of Clinical Oncology @ascocancer.bsky.social · 09/01/2026
We’re in for an engaging hour with an international & multidisciplinary hepatobiliary tumor board tackling complex HCC cases during the #GI26 “Liver Power Hour” chaired by Dr. Riad Salem & Dr. Nina Niu Sanford. #hpbcsm meetings.asco.org/meetings/202... @lorenzarimassa.bsky.social
011
Lorenza Rimassa @lorenzarimassa.bsky.social · 09/01/2026
Early morning start at @ascocancer.bsky.social #GI26 in San Francisco. Excited to meet friends and colleagues and discuss treatment options for patients with #HCC #CCA #BTC #PDAC #HumanitasUniversity #Humanitas
040
Lorenza Rimassa @lorenzarimassa.bsky.social · 03/12/2025
Traveling to Singapore for #ESMOAsia25. Looking forward to meeting with friends and colleagues and discussing new therapeutic options for patients with #GI cancers #HCC #CCA #BTC @myesmo.bsky.social
050
Lorenza Rimassa @lorenzarimassa.bsky.social · 14/11/2025
Please have a look at our editorial published in #ASCODailyNews @ascocancer.bsky.social @antoniodalessio.bsky.social @cirocelsa.bsky.social From Sorafenib to Precision Medicine: The Future of Systemic Therapy in Hepatocellular Carcinoma dailynews.ascopubs.org/do/sorafenib...
dailynews.ascopubs.org
From Sorafenib to Precision Medicine: The Future of Systemic Therapy in Hepatocellular Carcinoma
The treatment landscape for unresectable hepatocellular carcinoma has undergone profound change over the past 5 years, presenting both unprecedented opportunities and complex decision-making challenge...
032
Lorenza Rimassa @lorenzarimassa.bsky.social · 07/11/2025
Oral presentations on biliary tract cancer at AIOM | Associazione Italiana di Oncologia Medica annual congress. Congratulations to Chiara Pirrone and Virginia Genovesi for their studies on #BTC #CCA!
000
Reposted by Lorenza Rimassa
ESMO - European Society for Medical Oncology @myesmo.bsky.social · 25/10/2025
🤖 How can generative and foundation models reshape oncology, - from research to clinical practice? Find out in the session “Generative AI” at #ESMOAI25 in Berlin. 👉 www.esmo.org/meeting-cale...
041
Lorenza Rimassa @lorenzarimassa.bsky.social · 25/10/2025
JulieHeimbach discusses #livertransplant for patients with intrahepatic or perihilar #cholangiocarcinoma #CCA at the Advances in Hepatology Symposium in Berlin #FalkFoundation
000
Reposted by Lorenza Rimassa
ESMO - European Society for Medical Oncology @myesmo.bsky.social · 19/10/2025
🎥 50 years of key moments. ESMO’s 50th anniversary marks decades of achievements in #ScienceDissemination, #education and #collaboration. Take a selfie and share one of your milestones with #myESMOStory. #ESMO25 🔗 www.youtube.com/watch?v=dJTH...
043
Lorenza Rimassa @lorenzarimassa.bsky.social · 20/10/2025
@myesmo.bsky.social is where everything began, my first international oral presentation as a resident in medical oncology, my first international role as chair, discussant, invited speaker. I will always be grateful to #ESMO! #myESMOStory #ESMO25 #ESMOAmbassadors
041
Lorenza Rimassa @lorenzarimassa.bsky.social · 20/10/2025
It’s great to see a friend and colleague growing within @myesmo.bsky.social! #ESMO25 #myESMOStory #ESMOAmbassadors
021
Lorenza Rimassa @lorenzarimassa.bsky.social · 20/10/2025
James Harding presents phase 1 data showing a manageable safety profile and promising efficacy in advanced #PDAC at #ESMO25 #ESMOAmbassadors @myesmo.bsky.social
021
Reposted by Lorenza Rimassa
ESMO - European Society for Medical Oncology @myesmo.bsky.social · 20/10/2025
🎉 Your #myESMOStory moments made ESMO’s 50th anniversary special. From selfies at #ESMO25 to memories shared from afar, together we marked 50 years of progress in oncology. Here’s to accelerating impact! #ONEoncologycommunity
041
Lorenza Rimassa @lorenzarimassa.bsky.social · 20/10/2025
Do-Youn Oh discusses abstracts on #biliary tract cancer #BTC #CCA orally presented at #ESMO25 #ESMOAmbassadors @myesmo.bsky.social
021
Lorenza Rimassa @lorenzarimassa.bsky.social · 20/10/2025
Michele Reni presents novel findings from the #CASSANDRA phase 3 study of perioperative treatment in #PDAC #ESMO25 #ESMOAmbassadors @myesmo.bsky.social
021
Lorenza Rimassa @lorenzarimassa.bsky.social · 20/10/2025
IMMUNOBIL phase 2 study of immunotherapy #STRIDE for patients with previously treated advanced #BTC #CCA. Negative study but a subgroup of patients seem to benefit, we need biomarkers. #ESMO25 #ESMOAmbassadors @myesmo.bsky.social
011
Lorenza Rimassa @lorenzarimassa.bsky.social · 20/10/2025
Phase 2-3 ZSAB-neoGOLP trial of #neoadjuvant GOLP regimen for resectable i#CCA with high-risk features for recurrence. A positive interim analysis, but not a standard regimen. Novel approaches are needed. #ESMO25 #ESMOAmbassadors @myesmo.bsky.social
021
Lorenza Rimassa @lorenzarimassa.bsky.social · 20/10/2025
Milind Javle presents the results of #tinengotinib in patients with #CCA #BTC and #FGFR2 gene fusions previously treated with other FGFR inhibitors at #ESMO25 #ESMOAmbassadors @myesmo.bsky.social
022
Lorenza Rimassa @lorenzarimassa.bsky.social · 20/10/2025
@arndtvogel.bsky.social discusses #ABC-HCC and #TALENTop studies and puts them into the context. Positive studies, potential novel strategies, still open questions. Key message, #MDT is key in the management of patients with #HCC. #ESMO25 #ESMOAmbassadors @myesmo.bsky.social
011
Lorenza Rimassa @lorenzarimassa.bsky.social · 20/10/2025
Hui-Chuan Sun presents the #TALENTop phase 3 study of atezolizumab-bevacizumab followed by surgery in locally advanced #HCC. Positive study, #MDT discussion is key! #ESMO25 #ESMOAmbassadors @myesmo.bsky.social
022
Lorenza Rimassa @lorenzarimassa.bsky.social · 20/10/2025
Peter Galle presents ABC-HCC, academic study of atezolizumab-bevacizumab vs TACE for intermediate stage #HCC. Improved time to failure of treatment strategy with #systemic therapy. Positive study, potential novel approach for #intermediate HCC #ESMO25 #ESMOAmbassadors @myesmo.bsky.social
010
Lorenza Rimassa @lorenzarimassa.bsky.social · 19/10/2025
Interested in or worried about #LargeLanguageModels in #ClinicalPractice? The @myesmo.bsky.social Guidance (#ELCAP) is out and ready for download! #ESMO25 #ESMOAmbassadors
021
Reposted by Lorenza Rimassa
ESMO - European Society for Medical Oncology @myesmo.bsky.social · 19/10/2025
The ESMO Guidance on the use of #LargeLanguageModels in #ClinicalPractice (#ELCAP) is out: the first structured set of recommendations to bring #AI language models into #oncology safely and effectively. #ESMOAI25 #ESMO25 #LLMs #HealthAI 🔗 buff.ly/pg1gkiU
055
Lorenza Rimassa @lorenzarimassa.bsky.social · 19/10/2025
Stephen L. Chan discusses #CARES-009 and #SKYSCRAPER-14 phase 3 studies in #HCC at #ESMO25 #ESMOAmbassadors @myesmo.bsky.social
021
Lorenza Rimassa @lorenzarimassa.bsky.social · 19/10/2025
CARES-009 phase 3 study of perioperative camrelizumab and rivoceranib for #HCC #ESMO25 #ESMOAmbassadors @myesmo.bsky.social
032
Lorenza Rimassa @lorenzarimassa.bsky.social · 19/10/2025
Richard Finn presents the results of phase 3 IMbrave152/SkYSCRAPER-14 study at #ESMO25 Anti-TIGIT tiragolumab does not add benefit to atezolizumab-bevacizumab for patients with advanced #HCC #ESMOAmbassadors @myesmo.bsky.social
053
Lorenza Rimassa @lorenzarimassa.bsky.social · 19/10/2025
HRS-4642 combined with chemo in advanced #KRAS-G12D mutant #PDAC #ESMO25 #ESMOAmbassadors @myesmo.bsky.social
010
Lorenza Rimassa @lorenzarimassa.bsky.social · 18/10/2025
Breaking the boundaries in pancreatic cancer #PDAC #surveillance #risk #liquidbiopsy #ctDNA #KRAS #noveltherapies #ESMO25 #ESMOAmbassadors @benwestphalen.bsky.social @myesmo.bsky.social
041
Reposted by Lorenza Rimassa
ESMO - European Society for Medical Oncology @myesmo.bsky.social · 17/10/2025
🤝 #Mentorship is key for the #CareerDevelopment of #OncologyProfessionals. #myESMOStory Join us for a Mentor the Mentor session at #ESMO25! 📅 Saturday, 18 October 2025 | 11:30 – 12:30 | 📍 Erfurt Auditorium – CityCube A 🔗 ow.ly/PWWx50XbxHM
031
Lorenza Rimassa @lorenzarimassa.bsky.social · 17/10/2025
Matteo Simonelli presents the results for MK-1084 monotherapy in patients with #KRAS #G12C-mutated advanced solid tumors enrolled in the #phase1 KANDLELIT-001 study at #ESMO25 #ESMOAmbassadors @myesmo.bsky.social
031
Lorenza Rimassa @lorenzarimassa.bsky.social · 17/10/2025
Please join the @myesmo.bsky.social Climate Change Task Force session on Saturday to learn more about climate conscious cancer care. #ESMO4Climate #ESMO25 #ESMOAmbassadors
010
Lorenza Rimassa @lorenzarimassa.bsky.social · 17/10/2025
On my way to #ESMO25! I look forward to meeting friends and colleagues and discussing new data on hepatobiliary cancer #HCC #CCA #BTC. #ESMOAmbassadors @myesmo.bsky.social
031
Reposted by Lorenza Rimassa
ESMO - European Society for Medical Oncology @myesmo.bsky.social · 17/10/2025
📸 It is time for you to be a part of it: Share your #myESMOStory at #ESMO25. 🤳Find our selfie spots across the Congress venue and snap a photo—alone or with your team. 🔗 www.esmo.org/about-esmo/5...
022
Reposted by Lorenza Rimassa
ESMO - European Society for Medical Oncology @myesmo.bsky.social · 17/10/2025
At #ESMO25, explore how AI & digital tools are shaping oncology: 📌 AI-based image biomarkers 📌 Clinical trials in the age of AI 📌 Digital tools for off-site care 📌 ChatGPT & cancer care 📅 17–19 Oct
032
Reposted by Lorenza Rimassa
ESMO - European Society for Medical Oncology @myesmo.bsky.social · 17/10/2025
Tumour-agnostic therapies: ready for prime time? How do we accelerate adoption? At #ESMO25, follow two sessions on: Approved & emerging agnostic therapies Biomarkers & precision strategies Clinical, statistical & regulatory perspectives 18 & 20 Oct 🔗 ow.ly/VwE350XbbHy
021
Reposted by Lorenza Rimassa
ESMO - European Society for Medical Oncology @myesmo.bsky.social · 16/10/2025
👩‍⚕️ Young Oncologists at #ESMO25: mentorship, masterclasses, clinical cases, brunch sessions, Vesalius Talk, and more! Learn, connect, and grow from 17–20 Oct 🔗 ow.ly/BcZT50XaX79
032
Reposted by Lorenza Rimassa
ESMO - European Society for Medical Oncology @myesmo.bsky.social · 16/10/2025
Rolf Stahel, recipient of the 2025 ESMO Lifetime Achievement Award, will deliver his Award lecture at the #ESMO25 Opening Session, highlighting a career of impactful leadership in #ClinicalResearch, education, and international collaboration in oncology. 📅Don’t miss it 👉 ow.ly/IqFp50XceqP
041
Reposted by Lorenza Rimassa
ESMO - European Society for Medical Oncology @myesmo.bsky.social · 16/10/2025
Beyond immune checkpoint blockade: what’s next for #melanoma? At #ESMO25, explore: 📌 Why move beyond ICB 📌 #AdoptiveCellTherapy 📌 Treating unresectable stage IV melanoma 📌 Bispecific T-cell engagers 📅 17 Oct | 14:00–15:30 🔗 buff.ly/RaDTAFV
052
Reposted by Lorenza Rimassa
ESMO - European Society for Medical Oncology @myesmo.bsky.social · 16/10/2025
Glenda Ramos Martinez will receive the inaugural Oncologist of the Year Award for advancing oncology in Ecuador, expanding continuing medical education, and advocating for improved access to #CancerMedicines.
031
Reposted by Lorenza Rimassa
ESMO - European Society for Medical Oncology @myesmo.bsky.social · 16/10/2025
🔔 Heads up: the Late Breaking Abstracts of #ESMO25 will be available online at 00:05 on the day of their presentation. Stay tuned for the latest research breakthroughs and clinical changes in #oncology.
062
Reposted by Lorenza Rimassa
The Guardian @theguardian.com · 11/10/2025
Thousands gather in London in march for ‘lasting peace’ in Gaza
theguardian.com
Thousands gather in London in march for ‘lasting peace’ in Gaza
Director of Palestine Solidarity Campaign says ceasefire agreement says nothing about ‘system of apartheid’ in Palestine • Gaza ceasefire – live updates Thousands of people have gathered in central London to call for “lasting peace” in Gaza, a day after the ceasefire agreement between Israel and Hamas came into effect. The demonstration, organised by the Palestine Solidarity Campaign, began at Victoria Embankment on Saturday. Stalls sold keffiyehs and people handed out placards that read “from the river to the sea, Palestine will be free”, “it’s not a crime to act against genocide” and “Starmer has blood on his hands, free Palestine”. Continue reading...
2031483
Reposted by Lorenza Rimassa
The Guardian @theguardian.com · 11/10/2025
Diane Keaton, Oscar-winning star of Annie Hall and The Godfather, dies aged 79
theguardian.com
Diane Keaton, Oscar-winning star of Annie Hall and The Godfather, dies aged 79
The Oscar-winner best known for her many collaborations with Woody Allen, as well as films including Reds, The First Wives Club and The Book Club, has died Diane Keaton, one of the best-loved film stars of the past 50 years, has died at the age of 79 in California. The news was confirmed by People magazine. Further details are not available at this time, and her loved ones have asked for privacy, according to a family spokesperson. Continue reading...
44716270
Reposted by Lorenza Rimassa
ESMO - European Society for Medical Oncology @myesmo.bsky.social · 09/10/2025
Already registered for #ESMO25? Your Virtual Congress Bag is waiting! 📂 Access, view, and download all the essential materials designed to make your congress experience even better. Get your congress bag today! 🔗 ow.ly/XMXL50X96wY
041